Shares of Amgen Inc. (NASDAQ:AMGN – Get Free Report) have earned a consensus recommendation of “Hold” from the twenty-four ...

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look ...

Amgen (AMGN) ended the recent trading session at $314.38, demonstrating a -0.53% swing from the preceding day's closing price. The stock trailed the S&P 500, which registered a daily gain of 1.77%.

MariTide’s opportunity in diabetes should not be ignored. In addition to reducing weight by 17%, it reduced HbA1c up to 2.2% at 52 weeks. Treatment adherence is a major challenge in diabetes, and ...

Amgen (NasdaqGS:AMGN)'s recent affirmation of a $2.38 per share dividend for Q2 2025 could reflect investor confidence and perhaps aided in boosting its shares by 12% over the last quarter. The ...

Investment analysts at William Blair issued their Q4 2026 earnings per share estimates for Amgen in a research report issued to clients and investors on Wednesday, March 5th. William Blair analyst M.

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...

Amgen (NASDAQ:AMGN) shares snapped six straight sessions of gains, as the stock ended 3% lower at $306.2 on Wednesday. The biotechnology company gained 7.8% in the preceding six sessions.

Amgen's recent affirmation of a $2.38 per share dividend for Q2 2025 could reflect investor confidence and perhaps aided in boosting its shares by 12% over the last quarter. The company's ...